Mrs. Priya Kapoor, an Independent Non-Executive Director, holds a degree in Computer Science from IIT Mumbai and an MBA from IIM Ahmedabad, specializing in Marketing. Recognized as a distinguished alumna of both institutions, she has received awards for her leadership, including the Excellence in Leadership Award and Woman of the Year Award in Business Leadership. With over 25 years of experience, Mrs. Kapoor served as the CEO of a prominent IT solutions company. Her strategic acumen and commitment to excellence make her a valuable addition to the Board.
Mr. Rajesh Menon, a Chartered Accountant and an alumnus of the Indian Institute of Technology (IIT), brings over 35 years of diverse expertise. Formerly the Managing Partner of a leading financial consultancy firm, he has served on prominent regulatory bodies such as the SEBI Committee for Financial Market Infrastructure. Mr. Menon's contributions extend to industry leadership, including roles on the National Executive Committee of FICCI and the National Council of CII. His commitment to education is evident through advisory roles at IIT, and he is a respected co-author in financial reporting publications. With a legacy of leadership, Mr. Rajesh Menon enriches the company's governance and strategic direction.
Mrs. Anjali Desai is a Non-Executive Director of Brix Biopharma and a qualified Chartered Accountant with extensive expertise in financial, commercial, legal, and related areas. With a dedicated tenure spanning over 30 years, she has played a pivotal role in the growth and overall journey of Brix Biopharma. Mrs. Anjali Desai retired from the position of Whole-time Director in March 2020 and has since continued to contribute as a Non-Executive Director of the Company. Her wealth of experience and strategic insights greatly enrich the governance and development of Brix Biopharma.
Mr. Vikram Sharma is a seasoned executive with a diverse background. Holding a management degree from the prestigious Jamnalal Bajaj Institute of Management Studies, India, he brings a unique blend of skills to his professional journey.
Vikram has a rich history with McKinsey, where he dedicated 15 years of his career, ultimately reaching the position of partner. During his tenure, he co-led the healthcare practice in India and pioneered the Hospitals practice for Asia. His expertise extended to collaborating with leading pharmaceutical companies globally, focusing on core strategy, manufacturing productivity, R&D efficiency, portfolio management, M&A, and procurement initiatives.
Post McKinsey, from 2017 to 2019, Vikram advised various healthcare companies, providing leadership coaching and even contributing to academia by designing and teaching a problem-solving course at Ashoka University.
In August 2019, Vikram took on the role of CEO for Southeast Asia & the Middle East at OYO, a global travel-tech company. Under his leadership, the regions experienced substantial growth, doubling the number of hotels and homes. He successfully navigated the challenges brought about by the COVID crisis, significantly improving the contribution margin to a net positive territory.
Since March 2021, Vikram serves as the CEO of OYO Vacation Homes (OVH), Europe — a key market for the company. OVH stands as Europe's second-largest vacation homes company, comprising three acquired brands: DanCenter, Belvilla, and Traum FW. Vikram has accelerated their growth and profitability by integrating them into a tech-forward environment while preserving the unique legacies each brand has built over the decades.
Originally from Mumbai, Vikram currently resides in Gurgaon with his wife and 3-year-old son. In his leisure time, he enjoys the company of friends, watching movies, and exploring new outdoor pursuits.
Mr. Arjun Singh is an Independent Non-Executive Director of Brix Biopharma. He holds a Bachelor of Science degree in Biochemistry from Mumbai University and an MBA from the Indian School of Business (ISB). Boasting over 20 years of extensive experience in the pharmaceutical and biotech industries, his expertise encompasses strategic management, business development, and leadership roles across diverse global markets. Mr. Singh has been recognized for his outstanding contributions, receiving the Bio Excellence Award in Leadership. Currently, he serves as a consultant, providing strategic insights to organizations in the biopharmaceutical sector.
Mrs. Priya Sharma serves as an Independent Non-Executive Director and the Lead Independent Director at Brix Biopharma. She holds the position of Chairperson at the Research and Development Committee and is an Advisor to the Bioethics Council. Mrs. Sharma is also a Board Member of prominent organizations such as Johnson & Johnson and Bridge House Estates Foundation. She has a distinguished career in pharmaceutical research, with a focus on innovative drug discovery and development. Her leadership is instrumental in steering the company towards research excellence and strategic growth. Mrs. Sharma actively engages in philanthropic initiatives and serves on the Board of the Healthcare Foundation, contributing to healthcare access and community well-being. She holds a Ph.D. in Pharmaceutical Sciences from a leading research institution and has authored numerous publications in renowned scientific journals.
Dr. Rajesh Verma is an Independent Non-Executive Director of Brix Biopharma. With an illustrious career spanning over 30 years in the biopharmaceutical sector, he has held key positions at renowned companies, including Genentech, Biogen, Novartis, and Sun Pharma. Currently, Dr. Verma is the Chief Scientific Officer at Biotech Innovations, a leading biotechnology company.
His extensive expertise lies in research and development, regulatory affairs, and strategic leadership within the pharmaceutical industry. Dr. Verma has actively contributed to groundbreaking initiatives in drug discovery and development, showcasing his commitment to advancing medical science. He has also served on advisory boards for research institutions and is a sought-after speaker at international conferences.
Dr. Verma holds a Ph.D. in Biochemistry from Johns Hopkins University and has numerous research publications in reputable scientific journals. His academic and professional achievements underscore his dedication to advancing the field of biopharmaceuticals.
Mr. Prakash Sinha is a Non-Executive Director of Brix Biopharma and a qualified Chartered Accountant with extensive expertise in financial, commercial, legal, and related domains. With an illustrious career spanning over 30 years, Mr. Sinha has been an integral part of Brix Biopharma, contributing significantly to its overall journey and sustained growth.
Retiring from the position of Whole-time Director in November 2018, Mr. Prakash Sinha continues to serve as a Non-Executive Director, bringing a wealth of experience and strategic insights to the company. His dedicated leadership and comprehensive understanding of financial intricacies make him a valuable asset in shaping the governance and future development of Brix Biopharma.
Ms. Deepika Sharma is the Non-Executive Vice-Chairperson of Brix Biopharma and represents the second generation of the company's founding legacy. A science graduate from Bombay University, Ms. Sharma brings extensive expertise to various functions of the company, including production, technical areas, quality management, and general administration.
Having served in critical roles, Ms. Deepika Sharma retired as the Executive Vice-Chairperson of Brix Biopharma on March 31, 2022. Post-retirement, she continues to contribute as the Non-Executive Vice-Chairperson, starting April 1, 2022. Her steadfast commitment and diverse experience play a pivotal role in steering Brix Biopharma towards sustained growth and success.
Mr. Siddharth Desai is an Independent Non-Executive Director and the Lead Independent Director at Brix Biopharma. He serves as the Chairman of the Ethics and Governance Committee and is a key contributor to the strategic direction of the company. Mr. Desai holds additional roles as a Board Advisor to the US-India Strategic Partnership Forum and is actively involved in philanthropic initiatives, sitting on the Board of the Desai Foundation.
With a background in Mechanical Engineering from the Indian Institute of Technology, Mr. Siddharth Desai furthered his education with an MBA from Harvard Business School. He brings a wealth of experience, having retired as the Chairman of McKinsey, India, after an illustrious 34-year tenure, with the last decade spent shaping the firm's strategy in India.
Beyond McKinsey, Mr. Siddharth Desai has left a significant imprint on the global landscape, having led the Washington office of McKinsey and founded the Minneapolis office. He is also recognized as a co-editor of the influential book, 'Reimagining India,' which featured contributions from 60 prominent figures across various domains.
Mrs. Ananya Patel is an Independent Non-Executive Director at Brix Biopharma, bringing a wealth of experience in corporate leadership and strategy. She holds a B.A. (Hons.) in Economics from St. Stephen’s College, Delhi, and an MBA from the prestigious Indian Institute of Management, Kolkata.
With an illustrious career spanning over 25 years, Mrs. Patel has excelled in diverse roles across Asia, showcasing her proficiency in strategy, marketing, and leadership. Her extensive experience encompasses multiple disciplines, geographies, and cultures, making her a seasoned business leader.
Mrs. Ananya Patel has received several accolades in recognition of her outstanding contributions. In 2006, Business Today named her one of India's top 20 Business Women, and in 2009, the FICCI Women’s Organisation honored her with the Corporate Woman of the Year award.
Currently, Mrs. Patel is an esteemed independent Strategy and Marketing Consultant, providing valuable insights and guidance to businesses. Her strategic acumen and leadership prowess make her a valuable asset to Brix Biopharma's board.
Dr. Rajat Kapoor is a Non-Executive Director at Brix Biopharma and a distinguished Chartered Accountant with a wealth of experience in financial, commercial, legal, and related areas. With an extensive career spanning over 30 years, Dr. Kapoor has been an integral part of Brix Biopharma, playing a pivotal role in the company's overall journey and growth.
Having dedicated over three decades to Brix Biopharma, Dr. Rajat Kapoor retired from the position of Whole-time Director in November 2020. Despite his retirement from the executive role, he continues to contribute as a Non-Executive Director, providing valuable insights and strategic guidance to the company. His vast expertise and in-depth understanding of financial intricacies make Dr. Rajat Kapoor an invaluable asset to the governance and continued success of Brix Biopharma.
Mr. Arjun Mehta is the Chairman of Brix Biopharma, leading the company with a vision for excellence and innovation. Arjun holds a Master's degree in Business Administration with a specialization in Finance from the Harvard Business School. Prior to joining Brix Biopharma, he had a successful tenure with a leading investment bank, where he honed his skills in financial strategy and market dynamics.
Arjun's journey with Brix Biopharma began in 2010 when he assumed a pivotal role within the management team. Recognized for his strategic acumen, in 2012, he was appointed as the Head of Strategic Initiatives, overseeing critical projects that contributed to the company's growth trajectory. Arjun became an integral part of the Board of Directors in 2014 and, in recognition of his leadership and commitment, assumed the role of Chairman in 2017.
Under Arjun's guidance, Brix Biopharma has witnessed transformative initiatives and strategic partnerships. His leadership has been instrumental in navigating the company through global market challenges, and he has played a key role in shaping the corporate culture and fostering talent acquisition.
Arjun Mehta's commitment to excellence and his proactive approach to governance issues make him a vital force in driving Brix Biopharma's strategic priorities. He has been recognized for his outstanding contributions, receiving the 'Business Leader of the Year' award in 2019 from the Economic Times. His dynamic leadership has positioned Brix Biopharma as a key player in the biopharmaceutical industry.
Mrs. Niharika Sharma is an esteemed Independent Non-Executive Director of Brix Biopharma, bringing a wealth of knowledge and experience to the board. She holds a Bachelor's degree in Biochemistry from Delhi University and a Post Graduate Diploma in Business Administration with a specialization in Marketing from the Indian Institute of Management (IIM), Lucknow.
Mrs. Sharma is a recognized alumna of IIM, Lucknow, and her commitment to excellence has earned her accolades such as the 'Young Achiever Award' from the Confederation of Indian Industry (CII) and the 'Emerging Leader of the Year' award from the Business Today magazine. She has a diverse background with significant contributions to the pharmaceutical and healthcare sectors.
Mrs. Niharika Sharma's professional journey includes leadership roles in multinational corporations, where she has demonstrated strategic acumen and a passion for innovation. With a focus on sustainability and corporate responsibility, she has been instrumental in driving initiatives that align with Brix Biopharma's commitment to social and environmental stewardship.
Her dedication to fostering a culture of inclusivity and diversity is reflected in her active participation in industry forums, promoting best practices in corporate governance. Mrs. Sharma's leadership ethos aligns with Brix Biopharma's vision for global excellence, making her a valuable addition to the company's board.
Dr. Vikrant Patel is a distinguished Independent Non-Executive Director at Brix Biopharma, contributing his extensive expertise to the company's strategic vision and governance. Holding a Ph.D. in Pharmaceutical Sciences from the University of California, Berkeley, Dr. Patel's academic background is complemented by a Master's in Business Administration (MBA) from Stanford Graduate School of Business.
Dr. Patel has accumulated over 30 years of invaluable experience in the biopharmaceutical industry, showcasing his proficiency through key roles with renowned organizations such as Genentech, Biogen, Novartis, and Sun Pharma. Currently, he serves as the Chief Scientific Officer at Biotech Innovations, a leading biotechnology company.
His expertise spans various facets of the industry, including research and development, regulatory affairs, and strategic leadership. Dr. Patel has made significant contributions to groundbreaking initiatives in drug discovery and development, aligning with Brix Biopharma's commitment to innovation and excellence.
Beyond his corporate engagements, Dr. Vikrant Patel has been actively involved in industry and non-profit organizations, exemplifying his dedication to advancing the broader healthcare landscape. His appointment to the Brix Biopharma board brings a wealth of knowledge in manufacturing operations, quality control, supply chain management, and commercial operations.
Dr. Patel is a proud alumnus of Fairleigh Dickinson University, New Jersey, where he earned his Bachelor of Science in Business Management. His dynamic leadership and comprehensive industry insights make him a valuable asset to the board and the continued success of Brix Biopharma.
Ms. Deepa Joshi is a highly regarded Non-Executive Director at Brix Biopharma, bringing a wealth of expertise in finance, commerce, and legal affairs to the board. A qualified Chartered Accountant, Ms. Joshi has been a stalwart contributor to the pharmaceutical industry for over 30 years.
Her journey with Brix Biopharma began in 1988, and since then, Ms. Deepa Joshi has played an instrumental role in shaping the company's trajectory and overall growth. Her dedication to financial acumen and strategic leadership has left an indelible mark on Brix Biopharma's success.
Ms. Joshi retired from her position as Whole-time Director in November 2019, marking the culmination of a distinguished tenure of nearly three decades. However, her commitment to Brix Biopharma's success persists, as she continues to serve as a Non-Executive Director. Ms. Deepa Joshi's wealth of experience, coupled with her deep understanding of financial intricacies, adds significant value to the board's deliberations.
Her commitment to corporate governance and adherence to ethical standards make Ms. Deepa Joshi an essential figure in steering Brix Biopharma through its strategic initiatives. As a seasoned professional, she contributes to the company's success by providing valuable insights into financial, commercial, and legal aspects, ensuring sustainable growth and resilience.
Mr. Alok Sharma is the Chairman of Brix Biopharma, providing visionary leadership to the organization. Holding a Master's degree in Business Administration with a specialization in Finance from the Wharton School of the University of Pennsylvania, Mr. Sharma's educational background is complemented by extensive industry experience.
Joining Brix Biopharma in 2010, Mr. Alok Sharma swiftly became an integral part of the management team. In 2012, he assumed the role of Head of Strategic Initiatives, playing a crucial role in shaping the company's growth trajectory. His strategic acumen and dedication to excellence led to his appointment as Executive Director in 2014.
Elevated to the position of Chairman in 2017, Mr. Alok Sharma has been at the forefront of Brix Biopharma's transformative journey. Under his guidance, the company has successfully navigated global markets, making strategic acquisitions and expanding its global footprint. He has played a pivotal role in fostering a culture of innovation and sustainability within the organization.
Beyond his corporate responsibilities, Mr. Alok Sharma is actively involved in public advocacy, focusing on governance issues and fostering key global partnerships. Recognized for his exceptional leadership, he received the 'Business Leader of the Year' award in 2019 from the Economic Times.
His dynamic leadership and commitment to Brix Biopharma's strategic priorities make Mr. Alok Sharma a prominent figure in the biopharmaceutical industry.
Mrs. Neha Gupta is the Non-Executive Vice-Chairperson of Brix Biopharma, representing the second generation of the company's founding legacy. A distinguished science graduate from Bombay University, Mrs. Gupta brings a wealth of experience across various functions within the organization.
Having served in pivotal roles encompassing production, technical areas, quality management, and general administration, Mrs. Neha Gupta has played a crucial role in shaping the trajectory of Brix Biopharma. Her commitment to excellence and dedication to the company's core values have been instrumental in its continued success.
Retiring as the Executive Vice-Chairperson of Brix Biopharma on March 31, 2022, Mrs. Neha Gupta continues to contribute her valuable insights and leadership as the Non-Executive Vice-Chairperson since April 1, 2022. Her unwavering commitment to the company's growth and adherence to high standards of governance make her an essential figure in steering Brix Biopharma towards continued success.
Dr. Rajendra Singh is a distinguished Non-Executive Director of Brix Biopharma, bringing a wealth of expertise as a qualified Chartered Accountant. With a robust background in financial, commercial, and legal domains, Dr. Singh has been an integral part of the organization's growth journey.
His dedicated service spans over 35 years, contributing significantly to the overall success and trajectory of Brix Biopharma. Dr. Rajendra Singh retired from the position of Whole-time Director in November 2020, marking the culmination of a distinguished executive career.
Despite his retirement from the executive role, Dr. Singh continues to play a pivotal role as the Non-Executive Director of Brix Biopharma. His rich experience and strategic insights contribute to the company's governance and sustained growth.
Dr. Rajendra Singh's commitment to excellence and his comprehensive understanding of financial intricacies make him a valuable asset on the board. His continued involvement in guiding Brix Biopharma underscores his dedication to the company's mission and strategic vision.
Ms. Sneha Kapoor joined Brix Biopharma in 2017, assuming the role of Managing Director and Global Chief Executive Officer since September 2018. Armed with degrees in engineering, marketing, and finance, Sneha has a robust background, having previously worked with leading organizations such as Eicher Motors, PepsiCo, and Dr. Reddy’s.
With a career spanning almost two decades and roles in both India and the US, Ms. Kapoor brings a wealth of experience and a deep understanding of various facets of the global pharmaceutical business to Brix Biopharma. Since taking the helm as MD & GCEO, Sneha's strategic focus has been on propelling Brix Biopharma's growth, crafting and executing a roadmap to sustain momentum in domestic markets while expanding its footprint in other regions. Her priorities also include consolidating core focus areas, enhancing organizational capabilities, and fostering a future-ready workforce.
Recognized as an action-oriented industry leader, Ms. Sneha Kapoor is a proponent of agile business models, disruptive technologies, data-driven analytics, and a forward-thinking workforce. Her leadership aims to make a meaningful difference in the lives of patients while ensuring Brix Biopharma's continued success in the dynamic pharmaceutical landscape.